The Effect of Gastrografin and Glucagon on CT Scanning of the Pancreas: A Blind Clinical Trial
- 1 March 1978
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 126 (3) , 711-714
- https://doi.org/10.1148/126.3.711
Abstract
The effect of Gastrografin and glucagon on pancreatic CT [computed tomographic] scanning was studied in a blind clinical trial. Twenty-five patients had a pancreatic CT scan performed on an 18 s scanner and a repeat pancreatic CT scan following administration of Gastrografin and glucagon. The results were statistically significant: decreased streak artifacts; improved pancreatic head, body and tail delineation; and improved overall pancreatic visualization. Gastrografin-glucagon administration is recommended prior to pancreatic CT scanning if the scanning cycle is 18 s or longer.This publication has 3 references indexed in Scilit:
- Computerized tomography using the EMI general purpose scannerThe British Journal of Radiology, 1977
- Computed Tomography of the AbdomenRadiology, 1976
- Early Clinical Experience with Motionless Whole-Body Computed TomographyRadiology, 1976